| |
| |
|
| Insider
Information: |
Mueller Peter |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
311,837 |
|
|
Indirect Shares
|
25,571 |
|
|
| Direct
Value |
$69,223,526 |
|
|
|
Indirect Value
|
$12,292,747 |
|
|
| Total
Shares |
337,408 |
|
|
| Total
Value |
$81,516,273 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Global R&D, CSO |
2014-06-16 |
143,517 |
2014-06-16 |
25,571 |
Premium* |
|
|
Bioxcel Therapeutics Inc |
BTAI |
Director |
2019-08-23 |
168,320 |
2018-12-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
141 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
CSO&EVP Drug Innov&Realization |
• – – |
2006-12-19 |
4 |
AS |
$38.00 |
$6,270 |
D/D |
(165) |
52,747 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CSO & EVP Drug Innovation |
• – – |
2006-03-20 |
4 |
AS |
$40.00 |
$12,200 |
D/D |
(305) |
85,226 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP Drug Innov.& Realiz, CSO |
• – – |
2009-02-04 |
4 |
AS |
$33.55 |
$37,622 |
D/D |
(1,118) |
85,272 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2006-01-06 |
4 |
AS |
$30.78 |
$37,336 |
D/D |
(1,213) |
73,331 |
|
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Director |
– • – |
2018-12-06 |
4 |
B |
$5.00 |
$6,976 |
D/D |
1,395 |
150,920 |
2.39 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CSO & SVP Drug Discovery |
• – – |
2005-12-21 |
4 |
AS |
$27.84 |
$41,649 |
D/D |
(1,496) |
74,554 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP Drug Innov.& Realiz, CSO |
• – – |
2008-05-13 |
4 |
AS |
$27.00 |
$41,794 |
D/D |
(1,541) |
86,390 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Director |
– • – |
2019-08-23 |
4 |
B |
$9.34 |
$14,514 |
D/D |
1,554 |
168,320 |
2.39 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP Global R&D, CSO |
• – – |
2009-12-04 |
4 |
OE |
$10.41 |
$16,656 |
D/D |
1,600 |
118,474 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP Global R&D, CSO |
• – – |
2009-12-04 |
4 |
AS |
$39.62 |
$63,392 |
D/D |
(1,600) |
116,874 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP Global R&D, CSO |
• – – |
2010-01-15 |
4 |
OE |
$10.41 |
$16,656 |
D/D |
1,600 |
118,474 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP Global R&D, CSO |
• – – |
2010-01-15 |
4 |
AS |
$40.09 |
$64,519 |
D/D |
(1,600) |
116,874 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2010-02-16 |
4 |
AS |
$38.55 |
$61,680 |
D/D |
(1,600) |
125,505 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2010-02-16 |
4 |
OE |
$10.41 |
$16,656 |
D/D |
1,600 |
127,105 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2010-03-15 |
4 |
OE |
$10.41 |
$16,656 |
D/D |
1,600 |
127,105 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2010-03-15 |
4 |
AS |
$43.08 |
$68,928 |
D/D |
(1,600) |
125,505 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2010-04-15 |
4 |
OE |
$10.41 |
$16,656 |
D/D |
1,600 |
127,105 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2010-04-15 |
4 |
AS |
$39.61 |
$63,376 |
D/D |
(1,600) |
125,505 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2010-05-17 |
4 |
AS |
$37.39 |
$59,824 |
D/D |
(1,600) |
119,234 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2010-05-17 |
4 |
OE |
$10.41 |
$16,656 |
D/D |
1,600 |
120,834 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2010-06-15 |
4 |
AS |
$34.93 |
$55,888 |
D/D |
(1,600) |
119,234 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2010-06-15 |
4 |
OE |
$10.41 |
$16,656 |
D/D |
1,600 |
120,834 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2010-07-15 |
4 |
AS |
$34.24 |
$54,784 |
D/D |
(1,600) |
119,234 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2010-07-15 |
4 |
OE |
$10.41 |
$16,656 |
D/D |
1,600 |
120,834 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2010-08-16 |
4 |
OE |
$10.41 |
$16,656 |
D/D |
1,600 |
120,834 |
0 |
- |
|
141 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
